GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Vystar Corp (OTCPK:VYST) » Definitions » Equity-to-Asset

VYST (Vystar) Equity-to-Asset : -14.00 (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Vystar Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Vystar's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $-8.25 Mil. Vystar's Total Assets for the quarter that ended in Sep. 2024 was $0.59 Mil. Therefore, Vystar's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was -14.00.

The historical rank and industry rank for Vystar's Equity-to-Asset or its related term are showing as below:

VYST' s Equity-to-Asset Range Over the Past 10 Years
Min: -14   Med: -0.54   Max: -0.03
Current: -14

During the past 13 years, the highest Equity to Asset Ratio of Vystar was -0.03. The lowest was -14.00. And the median was -0.54.

VYST's Equity-to-Asset is ranked worse than
99.74% of 1566 companies
in the Chemicals industry
Industry Median: 0.58 vs VYST: -14.00

Vystar Equity-to-Asset Historical Data

The historical data trend for Vystar's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vystar Equity-to-Asset Chart

Vystar Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.11 -0.33 -0.45 -0.17 -10.18

Vystar Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.57 -10.18 -11.80 -12.54 -14.00

Competitive Comparison of Vystar's Equity-to-Asset

For the Specialty Chemicals subindustry, Vystar's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vystar's Equity-to-Asset Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Vystar's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Vystar's Equity-to-Asset falls into.


;
;

Vystar Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Vystar's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=-7.249/0.712
=-10.18

Vystar's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=-8.247/0.589
=-14.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vystar  (OTCPK:VYST) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Vystar Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Vystar's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Vystar Business Description

Traded in Other Exchanges
N/A
Address
365 Shrewsbury Street, Worcester, MA, USA, 01604
Vystar Corp is engaged in the rubber and plastic products market. It develops technology to produce Vytex Natural Rubber Latex which reduces antigenic protein and non-rubbers in natural rubber latex to undetectable levels. The company's products and services include Natural Rubber Latex, and clinical sleep diagnostics and durable medical equipment. The company derives revenue from sales of or license fees of Vytex NRL raw material to manufacturers and distributors of rubber and rubber end products.
Executives
Byron Lee Novosad other: Board Member 14019 SW FREEWAY, # 301 PMB 181, SUGAR LAND TX 77478
Bryan Lawrence Stone director C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
Keith D. Osborn 10 percent owner 5671 PEACHTREE-DUNWOODY RD., ATLANTA GA 30342
Paul R. Oristaglio director 955 COUNTY ROAD, BARRINGTON RI 02806
Steven Rotman director, officer: Chief Executive Officer C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
Joseph Carmen Allegra director C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
William R. Doyle director, officer: Chairman, President & CEO VYSTAR CORPORATION, 3235 SATELLITE BLVD, BUILDING 400, SUITE 290, DULUTH GA 30096
Joseph Allegra director VYSTAR CORPORATION, 3235 SATELLITE BLVD., BUILDING 400, SUITE 290, DULUTH GA 30096
Jason M. Meggs director C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Ranjit K. Matthan director C/O VYSTAR CORPORATION, 2484 BRIARCLIFF RD NE, SUITE 159, ATLANTA GA 30329
Mangum Michelle (mitsy) Y. director VYSTAR CORPORATION, 3235 SATELLITE BLVD, BUILDING 400, SUITE 290, DULUTH GA 30096
Michael X Ianacone director C/O VYSTAR CORPORATION, 2484 BRIARCLIFF RD NE, SUITE 159, ATLANTA GA 30329
Thomas L Mills director C/O WINSTON & STRAWN,, 1400 L. STREET, N.W, WASHINGTON DC 20005
Paul A. Yeoham director C/O VYSTAR CORP., 3235 SATELLITE BLVD., BUILDING 400, SUITE 290, DULUTH GA 30096
Dale Thomas Marsh director C/O VYSTAR CORPORATION, 3235 SATELLITE BLVD., BLDG. 400, STE 290, DULUTH GA 30096